FACTOR IXa INHIBITORS

The present invention provides a compound of Formula (I) where A is a heterocycle ring system and B is a heterocycle ring system or aryl ring system, and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, emb...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHEN, YILI, HIRABAYASHI, TOMOKAZU, GREENLEE, WILLIAM JOHN, CHAN, TIN YAN, SHERER, EDWARD, CAMPEAU, LOUISARLES, CHEN, YI-HENG, LI, DERUN, SMITH, CAMERON JAMES, CHACKALAMANNIL, SAMUEL, KATSUNO, MIKA, GUO, LIANGQIN, TAN, JOHN QIANG, BALKOVEC, JAMES
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CHEN, YILI
HIRABAYASHI, TOMOKAZU
GREENLEE, WILLIAM JOHN
CHAN, TIN YAN
SHERER, EDWARD
CAMPEAU, LOUISARLES
CHEN, YI-HENG
LI, DERUN
SMITH, CAMERON JAMES
CHACKALAMANNIL, SAMUEL
KATSUNO, MIKA
GUO, LIANGQIN
TAN, JOHN QIANG
BALKOVEC, JAMES
description The present invention provides a compound of Formula (I) where A is a heterocycle ring system and B is a heterocycle ring system or aryl ring system, and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2934536A4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2934536A4</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2934536A43</originalsourceid><addsrcrecordid>eNrjZBB1c3QO8Q9S8IxIVPD08_B08gTygnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgJGlsYmpsZmjiTERSgBnJR6m</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FACTOR IXa INHIBITORS</title><source>esp@cenet</source><creator>CHEN, YILI ; HIRABAYASHI, TOMOKAZU ; GREENLEE, WILLIAM JOHN ; CHAN, TIN YAN ; SHERER, EDWARD ; CAMPEAU, LOUISARLES ; CHEN, YI-HENG ; LI, DERUN ; SMITH, CAMERON JAMES ; CHACKALAMANNIL, SAMUEL ; KATSUNO, MIKA ; GUO, LIANGQIN ; TAN, JOHN QIANG ; BALKOVEC, JAMES</creator><creatorcontrib>CHEN, YILI ; HIRABAYASHI, TOMOKAZU ; GREENLEE, WILLIAM JOHN ; CHAN, TIN YAN ; SHERER, EDWARD ; CAMPEAU, LOUISARLES ; CHEN, YI-HENG ; LI, DERUN ; SMITH, CAMERON JAMES ; CHACKALAMANNIL, SAMUEL ; KATSUNO, MIKA ; GUO, LIANGQIN ; TAN, JOHN QIANG ; BALKOVEC, JAMES</creatorcontrib><description>The present invention provides a compound of Formula (I) where A is a heterocycle ring system and B is a heterocycle ring system or aryl ring system, and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160921&amp;DB=EPODOC&amp;CC=EP&amp;NR=2934536A4$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160921&amp;DB=EPODOC&amp;CC=EP&amp;NR=2934536A4$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHEN, YILI</creatorcontrib><creatorcontrib>HIRABAYASHI, TOMOKAZU</creatorcontrib><creatorcontrib>GREENLEE, WILLIAM JOHN</creatorcontrib><creatorcontrib>CHAN, TIN YAN</creatorcontrib><creatorcontrib>SHERER, EDWARD</creatorcontrib><creatorcontrib>CAMPEAU, LOUISARLES</creatorcontrib><creatorcontrib>CHEN, YI-HENG</creatorcontrib><creatorcontrib>LI, DERUN</creatorcontrib><creatorcontrib>SMITH, CAMERON JAMES</creatorcontrib><creatorcontrib>CHACKALAMANNIL, SAMUEL</creatorcontrib><creatorcontrib>KATSUNO, MIKA</creatorcontrib><creatorcontrib>GUO, LIANGQIN</creatorcontrib><creatorcontrib>TAN, JOHN QIANG</creatorcontrib><creatorcontrib>BALKOVEC, JAMES</creatorcontrib><title>FACTOR IXa INHIBITORS</title><description>The present invention provides a compound of Formula (I) where A is a heterocycle ring system and B is a heterocycle ring system or aryl ring system, and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBB1c3QO8Q9S8IxIVPD08_B08gTygnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgJGlsYmpsZmjiTERSgBnJR6m</recordid><startdate>20160921</startdate><enddate>20160921</enddate><creator>CHEN, YILI</creator><creator>HIRABAYASHI, TOMOKAZU</creator><creator>GREENLEE, WILLIAM JOHN</creator><creator>CHAN, TIN YAN</creator><creator>SHERER, EDWARD</creator><creator>CAMPEAU, LOUISARLES</creator><creator>CHEN, YI-HENG</creator><creator>LI, DERUN</creator><creator>SMITH, CAMERON JAMES</creator><creator>CHACKALAMANNIL, SAMUEL</creator><creator>KATSUNO, MIKA</creator><creator>GUO, LIANGQIN</creator><creator>TAN, JOHN QIANG</creator><creator>BALKOVEC, JAMES</creator><scope>EVB</scope></search><sort><creationdate>20160921</creationdate><title>FACTOR IXa INHIBITORS</title><author>CHEN, YILI ; HIRABAYASHI, TOMOKAZU ; GREENLEE, WILLIAM JOHN ; CHAN, TIN YAN ; SHERER, EDWARD ; CAMPEAU, LOUISARLES ; CHEN, YI-HENG ; LI, DERUN ; SMITH, CAMERON JAMES ; CHACKALAMANNIL, SAMUEL ; KATSUNO, MIKA ; GUO, LIANGQIN ; TAN, JOHN QIANG ; BALKOVEC, JAMES</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2934536A43</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>CHEN, YILI</creatorcontrib><creatorcontrib>HIRABAYASHI, TOMOKAZU</creatorcontrib><creatorcontrib>GREENLEE, WILLIAM JOHN</creatorcontrib><creatorcontrib>CHAN, TIN YAN</creatorcontrib><creatorcontrib>SHERER, EDWARD</creatorcontrib><creatorcontrib>CAMPEAU, LOUISARLES</creatorcontrib><creatorcontrib>CHEN, YI-HENG</creatorcontrib><creatorcontrib>LI, DERUN</creatorcontrib><creatorcontrib>SMITH, CAMERON JAMES</creatorcontrib><creatorcontrib>CHACKALAMANNIL, SAMUEL</creatorcontrib><creatorcontrib>KATSUNO, MIKA</creatorcontrib><creatorcontrib>GUO, LIANGQIN</creatorcontrib><creatorcontrib>TAN, JOHN QIANG</creatorcontrib><creatorcontrib>BALKOVEC, JAMES</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHEN, YILI</au><au>HIRABAYASHI, TOMOKAZU</au><au>GREENLEE, WILLIAM JOHN</au><au>CHAN, TIN YAN</au><au>SHERER, EDWARD</au><au>CAMPEAU, LOUISARLES</au><au>CHEN, YI-HENG</au><au>LI, DERUN</au><au>SMITH, CAMERON JAMES</au><au>CHACKALAMANNIL, SAMUEL</au><au>KATSUNO, MIKA</au><au>GUO, LIANGQIN</au><au>TAN, JOHN QIANG</au><au>BALKOVEC, JAMES</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FACTOR IXa INHIBITORS</title><date>2016-09-21</date><risdate>2016</risdate><abstract>The present invention provides a compound of Formula (I) where A is a heterocycle ring system and B is a heterocycle ring system or aryl ring system, and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP2934536A4
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title FACTOR IXa INHIBITORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T19%3A27%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHEN,%20YILI&rft.date=2016-09-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2934536A4%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true